Roche to acquire Poseida Therapeutics for $1.5bn
The partnership between Roche and Poseida began in 2022, focusing on the development of off-the-shelf CAR-T cell therapies. Credit: metamorworks/Shutterstock. Roche has signed an agreement
The partnership between Roche and Poseida began in 2022, focusing on the development of off-the-shelf CAR-T cell therapies. Credit: metamorworks/Shutterstock. Roche has signed an agreement
On certain subjects, it hardly sounds like John Kilian and Allison Cecil are part of the same political movement. Kilian, a retired IT professional and
Changes in administrations may create the specter of significant changes in antitrust enforcement. But I know from my own experience as policy director of the
As a physician, I was taught to appreciate the clinical importance of human touch for our physical and mental health. As a human being, I worry
The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These medications have made
LONDON — An experimental cancer treatment from Roche failed to improve survival in a major lung cancer study, the company said Tuesday, a result that
IMKELDI is the first oral liquid form of imatinib for specific leukaemia cancer forms. Credit: Jo Panuwat D/Shutterstock. The US Food and Drug Administration (FDA)
Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools
PCI Pharma Services, a leading contract development and manufacturing organization, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards for its innovation in
Depressed individuals who reflexively attempt to dampen their initial emotional responses to reminders of their negative memories have a low tolerance for distressing emotional stimuli